Ads
related to: Medicine Colitis- Patient Resources
Personalized Help
Every Step of the Way
- Injection Support
Hands-On Treatment Education
Enroll Now
- Patient Resources
Search results
AbbVie Completes Acquisition of Landos Biopharma
The Longview News-Journal· 7 days agoWith the completion of the acquisition, Landos is now part of AbbVie. Landos' lead investigational asset is NX-13, a first-in-class, oral NLRX1 agonist (a member of the NOD-like receptor family ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 7 days agoAbbVie Completes Acquisition of Landos Biopharma PR Newswire NORTH CHICAGO, Ill., May 23, 2024 - Adds first-in-class investigational asset, NX-13, to AbbVie's pipeline with the potential to offer a novel approach to the treatment of ulcerative
The biggest investments 23 ASCs have made in 2024
Becker's ASC Review· 2 days agoRunning an ASC is not without its costs. Facilities are forced to make investments every day to add new technologies, new staff members and level up care for their patients. Twenty-three healthcare ...
Ads
related to: Medicine Colitis
